Asthma
News
Sublingual immunotherapy for allergy-related asthma
Sublingual tablets containing house dust mite allergen immunotherapy extended the interval until a moderate or severe asthma exacerbation.
Conference Coverage
Cochrane Review nixes specific allergen immunotherapy for atopic dermatitis
Specific allergen immunotherapy “cannot be recommended for atopic eczema at present.”
Conference Coverage
Recently identified eczema comorbidities include anemia, obesity
WAIKOLOA, HAWAII – Fracture, cardiovascular disease, headaches, and other disorders are among the comorbid conditions associated with atopic...
News
First sublingual immunotherapy tablet for house dust mite allergic rhinitis may be U.S.-bound
A sublingual immunotherapy tablet for house dust mite–induced allergic rhinitis achieved clinically meaningful improvement in symptoms along with...
Conference Coverage
AAAAI: Risks comparable in adult asthma patients given fluticasone and salmeterol plus fluticasone combo
Key clinical point: A long-standing theory in asthma medicine is starting to be confirmed: Long-acting beta-agonists appear to be safe when used...
Conference Coverage
ACIP recommends LAIV as an option for all people with egg allergies
Live attenuated influenza vaccine will likely be recommended as an option for all individuals with egg allergies, regardless of the severity of...
Conference Coverage
VIDEO: Treating your atopic dermatitis patients more effectively
Dr. Adam Friedman discusses simple but effective ways to improve treatment of patients with atopic dermatitis at the 2016 ODAC annual meeting.
News
PPIs caused remission in about half of esophageal eosinophilia cases
About half of patients with symptomatic esophageal eosinophilia achieved complete clinical and histologic remission on proton pump inhibitors,...
News
Reslizumab: FDA panel recommends approval for adults, but not children
An FDA advisory committee voted to approve reslizumab, a Teva-sponsored drug treating severe asthma, for use in patients aged 18 years and older,...
News
FDA approves mepolizumab for use in combination with other asthma drugs
Nucala (mepolizumab) has been approved for use with other asthma medicines as maintenance therapy for patients aged 12 years and older with a...
Conference Coverage
EADV: Another promising topical for atopic dermatitis
Key clinical point: The pipeline for nonsteroidal topical therapies for pediatric and adult atopic dermatitis shows great promise. Major finding:...